2019 Interim Report Contents
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
2017 Annual Report 1 Definitions
* Bank of Jinzhou Co., Ltd. is not an authorized institution within the meaning of the Banking Ordinane (Chapter 155 of the Laws of Hong Kong), not subject to the supervision of the Hong Kong Monetary Authority, and not authorized to carry on banking and/or deposit-taking business in Hong Kong. Contents 2 Definitions 4 Chapter 1 Company Profile 7 Chapter 2 Financial Highlights 10 Chapter 3 Chairman ’s Statement 12 Chapter 4 President’s Statement 14 Chapter 5 Management Discussion and Analysis 71 Chapter 6 Changes in Ordinary Shares and Particulars of Shareholders 77 Chapter 7 Particulars of Preference Shares 79 Chapter 8 Directors, Supervisors, Senior Management, Employees and Organizations 98 Chapter 9 Corporate Governance Report 119 Chapter 10 Directors’ Report 127 Chapter 11 Supervisors’ Report 130 Chapter 12 Social Responsibility Report 132 Chapter 13 Internal Control and Internal Audit 136 Chapter 14 Important Events 139 Chapter 15 Independent Auditor’s Report 149 Chapter 16 Financial Statements 269 Chapter 17 Unaudited Supplementary Financial Information Bank of Jinzhou Co., Ltd. 2017 Annual Report 1 Definitions In this annual report, unless the context otherwise requires, the following terms shall have the meanings set out below: “A Share Offering” the Bank’s proposed initial public offering of not more than 1,927,000,000 A shares, which has been approved by the Shareholders on 29 June 2016 “Articles of Association” the articles of association of the Bank, as the same may be amended from time to time “the Bank”, “Bank of Jinzhou” -
Shengjing Bank Co., Ltd.* (A Joint Stock Company Incorporated in the People's Republic of China with Limited Liability) Stock Code: 02066 Annual Report Contents
Shengjing Bank Co., Ltd.* (A joint stock company incorporated in the People's Republic of China with limited liability) Stock Code: 02066 Annual Report Contents 1. Company Information 2 8. Directors, Supervisors, Senior 68 2. Financial Highlights 4 Management and Employees 3. Chairman’s Statement 7 9. Corporate Governance Report 86 4. Honours and Awards 8 10. Report of the Board of Directors 113 5. Management Discussion and 9 11. Report of the Board of Supervisors 121 Analysis 12. Social Responsibility Report 124 5.1 Environment and Prospects 9 13. Internal Control 126 5.2 Development Strategies 10 14. Independent Auditor’s Report 128 5.3 Business Review 11 15. Financial Statements 139 5.4 Financial Review 13 16. Notes to the Financial Statements 147 5.5 Business Overview 43 17. Unaudited Supplementary 301 5.6 Risk Management 50 Financial Information 6. Significant Events 58 18. Organisational Chart 305 7. Change in Share Capital and 60 19. The Statistical Statements of All 306 Shareholders Operating Institution of Shengjing Bank 20. Definition 319 * Shengjing Bank Co., Ltd. is not an authorised institution within the meaning of the Banking Ordinance (Chapter 155 of the Laws of Hong Kong), not subject to the supervision of the Hong Kong Monetary Authority, and not authorised to carry on banking and/or deposit-taking business in Hong Kong. COMPANY INFORMATION Legal Name in Chinese 盛京銀行股份有限公司 Abbreviation in Chinese 盛京銀行 Legal Name in English Shengjing Bank Co., Ltd. Abbreviation in English SHENGJING BANK Legal Representative ZHANG Qiyang Authorised Representatives ZHANG Qiyang and ZHOU Zhi Secretary to the Board of Directors ZHOU Zhi Joint Company Secretaries ZHOU Zhi and KWONG Yin Ping, Yvonne Registered and Business Address No. -
Table of Codes for Each Court of Each Level
Table of Codes for Each Court of Each Level Corresponding Type Chinese Court Region Court Name Administrative Name Code Code Area Supreme People’s Court 最高人民法院 最高法 Higher People's Court of 北京市高级人民 Beijing 京 110000 1 Beijing Municipality 法院 Municipality No. 1 Intermediate People's 北京市第一中级 京 01 2 Court of Beijing Municipality 人民法院 Shijingshan Shijingshan District People’s 北京市石景山区 京 0107 110107 District of Beijing 1 Court of Beijing Municipality 人民法院 Municipality Haidian District of Haidian District People’s 北京市海淀区人 京 0108 110108 Beijing 1 Court of Beijing Municipality 民法院 Municipality Mentougou Mentougou District People’s 北京市门头沟区 京 0109 110109 District of Beijing 1 Court of Beijing Municipality 人民法院 Municipality Changping Changping District People’s 北京市昌平区人 京 0114 110114 District of Beijing 1 Court of Beijing Municipality 民法院 Municipality Yanqing County People’s 延庆县人民法院 京 0229 110229 Yanqing County 1 Court No. 2 Intermediate People's 北京市第二中级 京 02 2 Court of Beijing Municipality 人民法院 Dongcheng Dongcheng District People’s 北京市东城区人 京 0101 110101 District of Beijing 1 Court of Beijing Municipality 民法院 Municipality Xicheng District Xicheng District People’s 北京市西城区人 京 0102 110102 of Beijing 1 Court of Beijing Municipality 民法院 Municipality Fengtai District of Fengtai District People’s 北京市丰台区人 京 0106 110106 Beijing 1 Court of Beijing Municipality 民法院 Municipality 1 Fangshan District Fangshan District People’s 北京市房山区人 京 0111 110111 of Beijing 1 Court of Beijing Municipality 民法院 Municipality Daxing District of Daxing District People’s 北京市大兴区人 京 0115 -
Annual Report 2019
HAITONG SECURITIES CO., LTD. 海通證券股份有限公司 Annual Report 2019 2019 年度報告 2019 年度報告 Annual Report CONTENTS Section I DEFINITIONS AND MATERIAL RISK WARNINGS 4 Section II COMPANY PROFILE AND KEY FINANCIAL INDICATORS 8 Section III SUMMARY OF THE COMPANY’S BUSINESS 25 Section IV REPORT OF THE BOARD OF DIRECTORS 33 Section V SIGNIFICANT EVENTS 85 Section VI CHANGES IN ORDINARY SHARES AND PARTICULARS ABOUT SHAREHOLDERS 123 Section VII PREFERENCE SHARES 134 Section VIII DIRECTORS, SUPERVISORS, SENIOR MANAGEMENT AND EMPLOYEES 135 Section IX CORPORATE GOVERNANCE 191 Section X CORPORATE BONDS 233 Section XI FINANCIAL REPORT 242 Section XII DOCUMENTS AVAILABLE FOR INSPECTION 243 Section XIII INFORMATION DISCLOSURES OF SECURITIES COMPANY 244 IMPORTANT NOTICE The Board, the Supervisory Committee, Directors, Supervisors and senior management of the Company warrant the truthfulness, accuracy and completeness of contents of this annual report (the “Report”) and that there is no false representation, misleading statement contained herein or material omission from this Report, for which they will assume joint and several liabilities. This Report was considered and approved at the seventh meeting of the seventh session of the Board. All the Directors of the Company attended the Board meeting. None of the Directors or Supervisors has made any objection to this Report. Deloitte Touche Tohmatsu (Deloitte Touche Tohmatsu and Deloitte Touche Tohmatsu Certified Public Accountants LLP (Special General Partnership)) have audited the annual financial reports of the Company prepared in accordance with PRC GAAP and IFRS respectively, and issued a standard and unqualified audit report of the Company. All financial data in this Report are denominated in RMB unless otherwise indicated. -
Addition of Clopidogrel to Aspirin in 45 852 Patients with Acute Myocardial Infarction: Randomised Placebo-Controlled Trial
Articles Addition of clopidogrel to aspirin in 45 852 patients with acute myocardial infarction: randomised placebo-controlled trial COMMIT (ClOpidogrel and Metoprolol in Myocardial Infarction Trial) collaborative group* Summary Background Despite improvements in the emergency treatment of myocardial infarction (MI), early mortality and Lancet 2005; 366: 1607–21 morbidity remain high. The antiplatelet agent clopidogrel adds to the benefit of aspirin in acute coronary See Comment page 1587 syndromes without ST-segment elevation, but its effects in patients with ST-elevation MI were unclear. *Collaborators and participating hospitals listed at end of paper Methods 45 852 patients admitted to 1250 hospitals within 24 h of suspected acute MI onset were randomly Correspondence to: allocated clopidogrel 75 mg daily (n=22 961) or matching placebo (n=22 891) in addition to aspirin 162 mg daily. Dr Zhengming Chen, Clinical Trial 93% had ST-segment elevation or bundle branch block, and 7% had ST-segment depression. Treatment was to Service Unit and Epidemiological Studies Unit (CTSU), Richard Doll continue until discharge or up to 4 weeks in hospital (mean 15 days in survivors) and 93% of patients completed Building, Old Road Campus, it. The two prespecified co-primary outcomes were: (1) the composite of death, reinfarction, or stroke; and Oxford OX3 7LF, UK (2) death from any cause during the scheduled treatment period. Comparisons were by intention to treat, and [email protected] used the log-rank method. This trial is registered with ClinicalTrials.gov, number NCT00222573. or Dr Lixin Jiang, Fuwai Hospital, Findings Allocation to clopidogrel produced a highly significant 9% (95% CI 3–14) proportional reduction in death, Beijing 100037, P R China [email protected] reinfarction, or stroke (2121 [9·2%] clopidogrel vs 2310 [10·1%] placebo; p=0·002), corresponding to nine (SE 3) fewer events per 1000 patients treated for about 2 weeks. -
Results Announcement for the Year Ended December 31, 2020
(GDR under the symbol "HTSC") RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2020 The Board of Huatai Securities Co., Ltd. (the "Company") hereby announces the audited results of the Company and its subsidiaries for the year ended December 31, 2020. This announcement contains the full text of the annual results announcement of the Company for 2020. PUBLICATION OF THE ANNUAL RESULTS ANNOUNCEMENT AND THE ANNUAL REPORT This results announcement of the Company will be available on the website of London Stock Exchange (www.londonstockexchange.com), the website of National Storage Mechanism (data.fca.org.uk/#/nsm/nationalstoragemechanism), and the website of the Company (www.htsc.com.cn), respectively. The annual report of the Company for 2020 will be available on the website of London Stock Exchange (www.londonstockexchange.com), the website of the National Storage Mechanism (data.fca.org.uk/#/nsm/nationalstoragemechanism) and the website of the Company in due course on or before April 30, 2021. DEFINITIONS Unless the context otherwise requires, capitalized terms used in this announcement shall have the same meanings as those defined in the section headed “Definitions” in the annual report of the Company for 2020 as set out in this announcement. By order of the Board Zhang Hui Joint Company Secretary Jiangsu, the PRC, March 23, 2021 CONTENTS Important Notice ........................................................... 3 Definitions ............................................................... 6 CEO’s Letter .............................................................. 11 Company Profile ........................................................... 15 Summary of the Company’s Business ........................................... 27 Management Discussion and Analysis and Report of the Board ....................... 40 Major Events.............................................................. 112 Changes in Ordinary Shares and Shareholders .................................... 149 Directors, Supervisors, Senior Management and Staff.............................. -
Annual Report Is Published
Contents 1. Company Information 2 8. Directors, Supervisors, Senior 73 2. Financial Highlights 4 Management and Employees 3. Chairman’s Statement 7 9. Corporate Governance Report 90 4. Honours and Awards 8 10. Report of the Board of Directors 117 5. Management Discussion and 9 11. Report of the Board of Supervisors 125 Analysis 12. Social Responsibility Report 128 5.1 Analysis of Overall 9 13. Internal Control 130 Operations 14. Independent Auditor’s Report 132 5.2 Financial Review 11 15. Financial Statements 142 5.3 Business Overview 44 16. Notes to the Financial Statements 150 5.4 Risk Management 52 17. Unaudited Supplementary 302 5.5 Environmental Outlook and 58 Financial Information Development Strategy 18. Organisational Chart 306 6. Significant Events 60 19. The Statistical Statements of All 307 7. Change in Share Capital and 64 Operating Institution of Shengjing Shareholders Bank 20. Definition 323 * Shengjing Bank Co., Ltd. is not an authorised institution within the meaning of the Banking Ordinance (Chapter 155 of the Laws of Hong Kong), not subject to the supervision of the Hong Kong Monetary Authority, and not authorised to carry on banking and/or deposit-taking business in Hong Kong. Chapter 1 Company Information COMPANY INFORMATION Legal Name in Chinese 盛京銀行股份有限公司 Abbreviation in Chinese 盛京銀行 Legal Name in English Shengjing Bank Co., Ltd. Abbreviation in English SHENGJING BANK Legal Representative QIU Huofa Authorised Representatives QIU Huofa and ZHOU Zhi Secretary to the Board of Directors ZHOU Zhi Joint Company Secretaries -
Hospicnursing of Patients with Advanced Tumor Li Jiaxin Liaoning Yingkou Hospital of Traditional Chinese Medicine, Yingkou City, Liaoning Province, China
Proceedings of Anticancer Research 2017; 1(2): 26-30 Proceedings of Anticancer Research HospicNursing of Patients with Advanced Tumor Li Jiaxin Liaoning Yingkou Hospital of Traditional Chinese Medicine, Yingkou City, Liaoning Province, China ARTICLE INFO ABSTRACT Article history: Purpose: Analyzing the nursing methods of patients with advanced tumor. Method: Choose 108 patients with advanced Published online: 30th Sept, 2017 tumor from the patients of the hospital. according to the nursing methods, each 54 patients are brought into the control group and the observation group respectively, which are given general Key words: nursing and hospic comprehensive nursing intervention measures, and use Self-rating depression scale (SDS) and Self-Rating Patients with advanced tumor Anxiety Scale (SAS) to evaluate the psychological situations of the Hospic nursing two groups before and after nursing, and to compare the life Effect quality situations and nursing satisfaction rate of the two group patients after nursing. Results: there is no significant difference in psychological status between the two groups before nursing (P > 0.05), but after nursing, the scores of SAS and SDS in the observation group were lower than those in the control group, and the difference is significant (P < 0.05), which is statistically significant. For the scores of the life quality, the observation group is higher than that of the control group, the difference is significant (P < 0.05), which is statistically significant. The nursing satisfaction rate of the observation group is 96.30% (52/54), higher than that of the control group (74.07% (40/54)), and the difference is significant (P < 0.05), which is statistically significant. -
Directors, Supervisors and Parties Involved in the [Redacted]
THIS DOCUMENT IS IN DRAFT FORM, INCOMPLETE AND SUBJECT TO CHANGE AND THAT THE INFORMATION MUST BE READ IN CONJUNCTION WITH THE SECTION HEADED “WARNING” ON THE COVER OF THIS DOCUMENT. DIRECTORS, SUPERVISORS AND PARTIES INVOLVED IN THE [REDACTED] DIRECTORS 3rd Sch(6) A1A41(1) Name Residential Address Nationality Executive Directors Mr. ZHANG Wei (張偉先生) Flat 15, Block A Chinese (Chairman) Wantong Apartment Shiying South Street Guta District Jinzhou City Liaoning Province PRC Ms. CHEN Man (陳漫女士) Unit 3-2-1601 Chinese Yanlord Riverside Plaza No. 131 Dongma Road Nankai District Tianjin City PRC Ms. ZHAO Jie (趙傑女士) Flat 10, Block E Chinese Wantong Apartment Guta District Jinzhou City Liaoning Province PRC Mr. WANG Jing (王晶先生) 7-III-13, Juhua Li Chinese Linghe District Jinzhou City Liaoning Province PRC Ms. WANG Xiaoyu Flat 65, Block I Chinese (王曉宇女士) Wantong Apartment Shiying South Street Guta District Jinzhou City Liaoning Province PRC —71— THIS DOCUMENT IS IN DRAFT FORM, INCOMPLETE AND SUBJECT TO CHANGE AND THAT THE INFORMATION MUST BE READ IN CONJUNCTION WITH THE SECTION HEADED “WARNING” ON THE COVER OF THIS DOCUMENT. DIRECTORS, SUPERVISORS AND PARTIES INVOLVED IN THE [REDACTED] Name Residential Address Nationality Non-executive Directors Mr. LI Dongjun (李東軍先生) No. 6, Level 15, Unit 1 Chinese No. 4 Xiuzhu Street Zhong Shan District Dalian City PRC Mr. ZHANG Caiguang 3002 Unit 2 Chinese (張財廣先生) Building No. 14 Court 8 Lize West Street Chaoyang District Beijing City PRC Mr. WU Zhengkui 703 Chinese (吳正奎先生) No. 34 Lane 2250 Dongjing Road Shanghai City PRC Ms. GU Jie (顧潔女士) 5-4-902 Dahezhuangyuan Chinese No. -
Evaluation of Water Resources Carrying Capacity Based on Cultivated Land and Urban Construction Scale -- a Case Study of Jinzhou City
E3S Web of Conferences 248, 03010 (2021) https://doi.org/10.1051/e3sconf/202124803010 CAES 2021 Evaluation of water resources carrying capacity based on cultivated land and urban construction scale -- a case study of Jinzhou City GAO Mengmeng1, Li Xiaolei1,a ,Yang Nan1, Sun Xiubo2, Liu Qiong1, Wang Yi1 1 China Institute of Geo-Environmental Monitoring, Beijing, China 2 Shenyang Geological Survey Center, CGS, Shenyang, China Abstract. Water resources play an important role in the natural environment, which is an irreplaceable resource for the survival and development of human society. Taking water resources as the research object, combined with the demand of social and economic development for water resources, this paper carried out the research on the evaluation method of cultivated land scale and urban construction scale under the constraints of water resources in Jinzhou. The results show that: the scale of cultivated land is 7215.98- 7843.20km2, which is in surplus. Heishan County has the largest scale of cultivated land and Guta District has the smallest scale of cultivated land. The urban construction land scale is 229.89-279.02 km2, which is in surplus. Taihe District and Yixian County are overloaded, and the rest are surplus. The evaluation results can support the determination and decomposition of planning objectives and indicators, and provide an important scientific basis for the implementation of local land spatial planning. 1 Introduction Water resources play an important role in the natural system.Naimi Ait-Aoudia[6]evaluated the sustainable environment, which is an irreplaceable resource for the population of Algiers in terms of water resources and survival and development of human society[1-3]. -
Minimum Wage Standards in China August 11, 2020
Minimum Wage Standards in China August 11, 2020 Contents Heilongjiang ................................................................................................................................................. 3 Jilin ............................................................................................................................................................... 3 Liaoning ........................................................................................................................................................ 4 Inner Mongolia Autonomous Region ........................................................................................................... 7 Beijing......................................................................................................................................................... 10 Hebei ........................................................................................................................................................... 11 Henan .......................................................................................................................................................... 13 Shandong .................................................................................................................................................... 14 Shanxi ......................................................................................................................................................... 16 Shaanxi ...................................................................................................................................................... -
中國內地指定醫院列表 出版日期: 2019 年 7 月 1 日 Designated Hospital List in Mainland China Published Date: 1 Jul 2019
中國內地指定醫院列表 出版日期: 2019 年 7 月 1 日 Designated Hospital List in Mainland China Published Date: 1 Jul 2019 省 / 自治區 / 直轄市 醫院 地址 電話號碼 Provinces / 城市/City Autonomous Hospital Address Tel. No. Regions / Municipalities 中國人民解放軍第二炮兵總醫院 (第 262 醫院) 北京 北京 西城區新街口外大街 16 號 The Second Artillery General Hospital of Chinese 10-66343055 Beijing Beijing 16 Xinjiekou Outer Street, Xicheng District People’s Liberation Army 中國人民解放軍總醫院 (第 301 醫院) 北京 北京 海澱區復興路 28 號 The General Hospital of Chinese People's Liberation 10-82266699 Beijing Beijing 28 Fuxing Road, Haidian District Army 北京 北京 中國人民解放軍第 302 醫院 豐台區西四環中路 100 號 10-66933129 Beijing Beijing 302 Military Hospital of China 100 West No.4 Ring Road Middle, Fengtai District 中國人民解放軍總醫院第一附屬醫院 (中國人民解 北京 北京 海定區阜成路 51 號 放軍 304 醫院) 10-66867304 Beijing Beijing 51 Fucheng Road, Haidian District PLA No.304 Hospital 北京 北京 中國人民解放軍第 305 醫院 西城區文津街甲 13 號 10-66004120 Beijing Beijing PLA No.305 Hospital 13 Wenjin Street, Xicheng District 北京 北京 中國人民解放軍第 306 醫院 朝陽區安翔北里 9 號 10-66356729 Beijing Beijing The 306th Hospital of PLA 9 Anxiang North Road, Chaoyang District 中國人民解放軍第 307 醫院 北京 北京 豐台區東大街 8 號 The 307th Hospital of Chinese People’s Liberation 10-66947114 Beijing Beijing 8 East Street, Fengtai District Army 中國人民解放軍第 309 醫院 北京 北京 海澱區黑山扈路甲 17 號 The 309th Hospital of Chinese People’s Liberation 10-66775961 Beijing Beijing 17 Heishanhu Road, Haidian District Army 中國人民解放軍第 466 醫院 (空軍航空醫學研究所 北京 北京 海澱區北窪路北口 附屬醫院) 10-81988888 Beijing Beijing Beiwa Road North, Haidian District PLA No.466 Hospital 北京 北京 中國人民解放軍海軍總醫院 (海軍總醫院) 海澱區阜成路 6 號 10-66958114 Beijing Beijing PLA Naval General Hospital 6 Fucheng Road, Haidian District 北京 北京 中國人民解放軍空軍總醫院 (空軍總醫院) 海澱區阜成路 30 號 10-68410099 Beijing Beijing Air Force General Hospital, PLA 30 Fucheng Road, Haidian District 中華人民共和國北京市昌平區生命園路 1 號 北京 北京 北京大學國際醫院 Yard No.1, Life Science Park, Changping District, Beijing, 10-69006666 Beijing Beijing Peking University International Hospital China, 東城區南門倉 5 號(西院) 5 Nanmencang, Dongcheng District (West Campus) 北京 北京 北京軍區總醫院 10-66721629 Beijing Beijing PLA.